FDA-Catalyst Projects

This page provides access to FDA-Catalyst projects funded by the U.S. Food and Drug Administration. 

About FDA-Catalyst

FDA-Catalyst supplements the Sentinel System. The data FDA-Catalyst provides comes from interactions with patients and/or providers. FDA-Catalyst combines this data with data included in the Sentinel infrastructure.

FDA-Catalyst is an important addition to surveillance and research of marketed medical products. It leverages the Sentinel Infrastructure and other capabilities of the Sentinel System to answer a wider range of questions than can be addressed by the Sentinel System data alone. These activities ultimately complement the existing postmarket surveillance system.

Current and completed activities are included in the table below.

RSS Feed Scroll to Top